BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xuan W, Peng Y, Deng Z, Peng T, Kuai H, Li Y, He J, Jin C, Liu Y, Wang R, Tan W. A basic insight into aptamer-drug conjugates (ApDCs). Biomaterials 2018;182:216-26. [PMID: 30138784 DOI: 10.1016/j.biomaterials.2018.08.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Leone G, Consumi M, Pepi S, Pardini A, Bonechi C, Tamasi G, Donati A, Rossi C, Magnani A. Poly-vinyl alcohol (PVA) crosslinked by trisodium trimetaphosphate (STMP) and sodium hexametaphosphate (SHMP): Effect of molecular weight, pH and phosphorylating agent on length of spacing arms, crosslinking density and water interaction. Journal of Molecular Structure 2020;1202:127264. [DOI: 10.1016/j.molstruc.2019.127264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhu L, Yang J, Ma Y, Zhu X, Zhang C. Aptamers Entirely Built from Therapeutic Nucleoside Analogues for Targeted Cancer Therapy. J Am Chem Soc . [DOI: 10.1021/jacs.1c09574] [Reference Citation Analysis]
3 Li L, Xu S, Yan H, Li X, Yazd HS, Li X, Huang T, Cui C, Jiang J, Tan W. Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives. Angew Chem Int Ed Engl 2021;60:2221-31. [PMID: 32282107 DOI: 10.1002/anie.202003563] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
4 Li L, Xu S, Yan H, Li X, Yazd HS, Li X, Huang T, Cui C, Jiang J, Tan W. Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives. Angew Chem 2021;133:2249-59. [DOI: 10.1002/ange.202003563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Shrivastava G, Bakshi HA, Aljabali AA, Mishra V, Hakkim FL, Charbe NB, Kesharwani P, Chellappan DK, Dua K, Tambuwala MM. Nucleic Acid Aptamers as a Potential Nucleus Targeted Drug Delivery System. Curr Drug Deliv 2020;17:101-11. [PMID: 31906837 DOI: 10.2174/1567201817666200106104332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Salaheldin TA, Bharali DJ, Mousa SA. Functionalized nano-targeted moieties in management of prostate cancer. Future Oncol 2020;16:869-83. [PMID: 32292071 DOI: 10.2217/fon-2019-0635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Gao F, Zhou J, Sun Y, Yang C, Zhang S, Wang R, Tan W. Programmable Repurposing of Existing Drugs as Pharmaceutical Elements for the Construction of Aptamer-Drug Conjugates. ACS Appl Mater Interfaces 2021;13:9457-63. [PMID: 33356116 DOI: 10.1021/acsami.0c18846] [Reference Citation Analysis]
8 Park JY, Chae JR, Cho YL, Kim Y, Lee D, Lee JK, Kang WJ. Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer. Pharmaceutics 2020;12:E985. [PMID: 33080969 DOI: 10.3390/pharmaceutics12100985] [Reference Citation Analysis]
9 Peng T, Deng Z, He J, Li Y, Tan Y, Peng Y, Wang X, Tan W. Functional nucleic acids for cancer theranostics. Coordination Chemistry Reviews 2020;403:213080. [DOI: 10.1016/j.ccr.2019.213080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
10 Tan Y, Peng Y, Ai L, Li Y, Qu YX, Wang D, Su Y, Deng T, Fu T, Zhao Z, Wang XQ, Tan W. Aptamer Enables Consistent Maytansine Delivery through Maintaining Receptor Homeostasis for HER2 Targeted Cancer Therapy. Bioconjug Chem 2020;31:1766-74. [PMID: 32463664 DOI: 10.1021/acs.bioconjchem.0c00250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Deng Z, Liu S. Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles. Journal of Controlled Release 2020;326:276-96. [DOI: 10.1016/j.jconrel.2020.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
12 Huang J, Chen X, Fu X, Li Z, Huang Y, Liang C. Advances in Aptamer-Based Biomarker Discovery. Front Cell Dev Biol 2021;9:659760. [PMID: 33796540 DOI: 10.3389/fcell.2021.659760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Wang M, Shu XS, Li M, Zhang Y, Yao Y, Huang X, Li J, Wei P, He Z, Lu J, Ying Y. A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer. Front Oncol 2021;11:737323. [PMID: 34858817 DOI: 10.3389/fonc.2021.737323] [Reference Citation Analysis]
14 Han J, Gao L, Wang J, Wang J. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy. J Cancer 2020;11:6902-15. [PMID: 33123281 DOI: 10.7150/jca.49532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Jiang T, Zhou L, Liu H, Zhang P, Liu G, Gong P, Li C, Tan W, Chen J, Cai L. Monitorable Mitochondria-Targeting DNAtrain for Image-Guided Synergistic Cancer Therapy. Anal Chem 2019;91:6996-7000. [DOI: 10.1021/acs.analchem.9b01777] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
16 Deng Z, Yang Q, Peng Y, He J, Xu S, Wang D, Peng T, Wang R, Wang XQ, Tan W. Polymeric Engineering of Aptamer-Drug Conjugates for Targeted Cancer Therapy. Bioconjug Chem 2020;31:37-42. [PMID: 31815437 DOI: 10.1021/acs.bioconjchem.9b00715] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
17 Sun Y, Gao F, Yang C, Li Y, Jin C, Xie S, Lv C, Ding D, Han D, Li J, Wang R, Tan W. Construction of Bispecific Aptamer-Drug Conjugate by a Hybrid Chemical and Biological Approach. Bioconjug Chem 2020;31:1289-94. [PMID: 32223180 DOI: 10.1021/acs.bioconjchem.0c00071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang QL, Huang WX, Zhang PJ, Chen L, Lio CK, Zhou H, Qing LS, Luo P. Colorimetric determination of the early biomarker hypoxia-inducible factor-1 alpha (HIF-1α) in circulating exosomes by using a gold seed-coated with aptamer-functionalized Au@Au core-shell peroxidase mimic. Mikrochim Acta 2019;187:61. [PMID: 31853650 DOI: 10.1007/s00604-019-4035-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
19 Yoon S, Go G, Yoon Y, Lim J, Lee G, Lee S. Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases. Biomolecules 2021;11:784. [PMID: 34067472 DOI: 10.3390/biom11060784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Dal Corso A, Pignataro L, Belvisi L, Gennari C. Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates. Chem Eur J 2019;25:14740-57. [DOI: 10.1002/chem.201903127] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
21 Huang Z, Wang D, Long CY, Li SH, Wang XQ, Tan W. Regulating the Anticancer Efficacy of Sgc8-Combretastatin A4 Conjugates: A Case of Recognizing the Significance of Linker Chemistry for the Design of Aptamer-Based Targeted Drug Delivery Strategies. J Am Chem Soc 2021;143:8559-64. [PMID: 34097382 DOI: 10.1021/jacs.1c03013] [Reference Citation Analysis]
22 Duan B, Zou S, Sun Y, Xu X. Fabrication of tumor-targeting composites based on the triple helical β-glucan through conjugation of aptamer. Carbohydr Polym 2021;254:117476. [PMID: 33357929 DOI: 10.1016/j.carbpol.2020.117476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Um W, Park J, Ko H, Lim S, Yoon HY, Shim MK, Lee S, Ko YJ, Kim MJ, Park JH, Lim DK, Byun Y, Kwon IC, Kim K. Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy. Biomaterials 2019;224:119494. [PMID: 31542518 DOI: 10.1016/j.biomaterials.2019.119494] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
24 Safari Yazd H, Yang Y, Li L, Yang L, Li X, Pan X, Chen Z, Jiang J, Cui C, Tan W. Precise Deposition of Polydopamine on Cancer Cell Membrane as Artificial Receptor for Targeted Drug Delivery. iScience 2020;23:101750. [PMID: 33367224 DOI: 10.1016/j.isci.2020.101750] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang L, Zhou L, Zhang H, Zhang Y, Li L, Xie T, Chen Y, Li X, Ling N, Dai J, Sun X, Liu J, Zhao J, Peng T, Ye M. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for In Vivo Imaging. ACS Appl Mater Interfaces 2021;13:54656-64. [PMID: 34779207 DOI: 10.1021/acsami.1c12391] [Reference Citation Analysis]
26 Uemachi H, Kasahara Y, Tanaka K, Okuda T, Yoneda Y, Obika S. Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity. Pharmaceutics 2021;13:888. [PMID: 34204006 DOI: 10.3390/pharmaceutics13060888] [Reference Citation Analysis]
27 Huang X, Blum NT, Lin J, Shi J, Zhang C, Huang P. Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy. Mater Horiz 2021;8:78-101. [DOI: 10.1039/d0mh00715c] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Alamoudi AO. Radiomics, aptamers and nanobodies: New insights in cancer diagnostics and imaging. Hum Antibodies 2021;29:1-15. [PMID: 33554897 DOI: 10.3233/HAB-200436] [Reference Citation Analysis]
29 Tran BT, Kim J, Ahn DR. Systemic delivery of aptamer-drug conjugates for cancer therapy using enzymatically generated self-assembled DNA nanoparticles. Nanoscale 2020;12:22945-51. [PMID: 33188383 DOI: 10.1039/d0nr05652a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Yang Q, Deng Z, Wang D, He J, Zhang D, Tan Y, Peng T, Wang XQ, Tan W. Conjugating Aptamer and Mitomycin C with Reductant-Responsive Linker Leading to Synergistically Enhanced Anticancer Effect. J Am Chem Soc 2020;142:2532-40. [PMID: 31910340 DOI: 10.1021/jacs.9b12409] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
31 Bing T, Zhang N, Shangguan D. Cell-SELEX, an Effective Way to the Discovery of Biomarkers and Unexpected Molecular Events. Adv Biosyst 2019;3:e1900193. [PMID: 32648677 DOI: 10.1002/adbi.201900193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]